Your browser doesn't support javascript.
loading
Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer.
Reesink, Daan J; van Melick, Harm H E; van der Nat, Paul B; Los, Maartje; Horenblas, Simon; van de Garde, Ewoudt M W.
Afiliação
  • Reesink DJ; Department of Urology, St. Antonius Hospital Nieuwegein/Utrecht, Koekoekslaan 1, 3435CM, Nieuwegein, The Netherlands. d.reesink@antoniusziekenhuis.nl.
  • van Melick HHE; Department of Urology, St. Antonius Hospital Nieuwegein/Utrecht, Koekoekslaan 1, 3435CM, Nieuwegein, The Netherlands.
  • van der Nat PB; Division Value Based Healthcare, St. Antonius Hospital Nieuwegein/Utrecht, Nieuwegein, The Netherlands.
  • Los M; Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud UMC Nijmegen, Nijmegen, The Netherlands.
  • Horenblas S; Department of Oncology, St. Antonius Hospital Nieuwegein/Utrecht, Nieuwegein, The Netherlands.
  • van de Garde EMW; Department of Urology, The Netherlands Cancer Institute Amsterdam, Amsterdam, The Netherlands.
World J Urol ; 41(6): 1551-1562, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37145158
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article